Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Plan for Accountability Set yourself up with a tracking app, a buddy system, or a weekly check-in to stay on course
No problems
prescribed off-label for weight loss Estimated retail price: $950$1,200/month Zepbound (tirzepatide) FDA approved for weight loss Estimated retail price: $1,080$1,200/month Mounjaro (tirzepatide) FDA approved for type 2 diabetes
Its FDA-approved use is for treating HIV-associated lipodystrophy, or excess abdominal fat accumulation resulting from antiretroviral therapy, and it has fared well in its specialty
Novo Nordisk has criticised as insufficient a recent study suggesting that people using Ozempic or Wegovy for treating obesity or type 2 diabetes may have an increased risk of developing a rare form of blindness
